SN.L
SMITH & NEPHEW PLC ORD USD0.20
Healthcare · in the FTSE 100
📍 London, United Kingdom · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
Key figures, against the FTSE 100
Figures as of 5 Nov 2026, refreshed weekly
Each bar places this company among the FTSE 100 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
21.2x
The share price is 21.2 times the last twelve months' earnings per share.
P/E on average earnings?
35.4x
The share price is 35.4 times earnings per share averaged over recent years.
Price / book
2.6x
The market values the company at 2.6 times the accounting value of its equity.
EV / EBIT?
17.2x
The company's value including its debt is 17.2 times its operating profit.
Free cash flow yield?
7.9%
Free cash flow equals 7.9% of the company's market value.
Profitability
Return on equity?
11.9%
Each 100 of shareholders' money produced 11.9 of net profit.
Return on assets?
5.2%
Each 100 of assets produced 5.2 of net profit.
Return on invested capital
9.2%
Each 100 invested by lenders and owners produced 9.2 of profit.
Operating margin?
15.5%
Of every 100 in sales, 15.5 was left as operating profit.
Debt
Debt / equity?
73.1%
Total debt equals 73% of shareholders' equity.
Net debt / EBITDA?
2.2x
Net debt equals 2.2 years of operating earnings (EBITDA).
Interest cover
5.4x
Operating profit was 5.4 times the interest bill.
Growth
Revenue growth
11.6%
Latest revenue is 11.6% above the average of earlier reported years.
Earnings growth
108.8%
Latest net profit is 108.8% above the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.